Willow Biosciences (TSE:WLLW) Stock Price Down 12.5% – Time to Sell?

Willow Biosciences Inc. (TSE:WLLWGet Free Report) shares were down 12.5% during trading on Monday . The company traded as low as C$0.04 and last traded at C$0.04. Approximately 566,500 shares were traded during trading, an increase of 40% from the average daily volume of 403,974 shares. The stock had previously closed at C$0.04.

Willow Biosciences Stock Down 12.5 %

The stock has a market cap of C$5.07 million, a price-to-earnings ratio of -0.64 and a beta of 1.13. The business has a fifty day moving average of C$0.04 and a 200 day moving average of C$0.07. The company has a debt-to-equity ratio of 902.05, a current ratio of 0.80 and a quick ratio of 19.71.

Willow Biosciences Company Profile

(Get Free Report)

Willow Biosciences Inc is a Canadian biotechnology company based in Calgary. It produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Geographically, it derives a majority of revenue from Canada.

See Also

Receive News & Ratings for Willow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Willow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.